Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
Issues: Whether the imported Cimetidine Powder, classified by the Revenue under Item 68, was entitled to the benefit of Notification No. 234/82-C.E. and the consequential refund relief, including adjustment against the proforma credit already availed.
Analysis: The Revenue's classification of the goods under Item 68 was not disputed in appeal. On that footing, the goods fell within the line of decisions holding that Cimetidine, as a bulk drug covered by the notification, was eligible for the exemption from C.V.D. under Notification No. 234/82-C.E. The plea for the notification benefit could be entertained because it flowed from the classification adopted by the Revenue. As the appellants had already availed proforma credit under Rule 56A of the Central Excise Rules, 1944, the refund arising from the present order was directed to be adjusted against that credit, with the bank guarantee and undertaking to stand discharged thereafter.
Conclusion: The exemption benefit was available and the appeal succeeded with consequential relief, subject to adjustment of the refund against the proforma credit already taken.
Ratio Decidendi: Where the Revenue's classification itself brings the goods within the scope of an exemption notification, the benefit of that notification may be granted even if not claimed earlier, and the resulting refund may be adjusted against proforma credit already availed.